Clinuvel Pharmaceuticals Limited (CLVLY)

Clinuvel Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 28, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	361	514	588	506	1,137	875
Market Cap Growth	-31.82%	-12.65%	16.31%	-55.55%	29.97%	-24.32%
Enterprise Value	235	398	495	438	1,084	836
Last Close Price	7.20	9.77	11.91	10.19	22.67	17.40
PE Ratio	15.03	21.60	28.87	35.14	61.34	84.20
PS Ratio	6.40	8.73	11.28	11.16	31.39	38.92
PB Ratio	2.68	3.79	5.37	5.84	15.36	17.59
P/TBV Ratio	2.69	3.80	5.37	5.85	15.39	17.63
P/FCF Ratio	24.81	24.46	24.62	18.61	82.41	95.30
P/OCF Ratio	24.47	20.77	23.93	18.40	78.75	89.33
EV/Sales Ratio	4.03	6.76	9.50	9.68	29.91	37.16
EV/EBITDA Ratio	7.05	12.09	16.71	17.68	49.73	97.48
EV/EBIT Ratio	7.21	12.28	16.86	17.89	50.60	98.79
EV/FCF Ratio	16.13	18.95	20.73	16.13	78.52	91.00
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	0.01	0.02	0.02	0.03	0.04	0.10
Debt / FCF Ratio	0.03	0.03	0.03	0.03	0.07	0.10
Asset Turnover	0.41	0.42	0.46	0.52	0.51	0.45
Inventory Turnover	0.76	0.77	1.33	3.69	1.87	4.26
Quick Ratio	16.37	8.33	7.02	10.03	11.35	8.88
Current Ratio	17.37	8.81	7.44	10.24	11.81	9.10
Return on Equity (ROE)	19.59%	19.39%	21.09%	18.62%	28.95%	23.29%
Return on Assets (ROA)	14.22%	14.29%	16.34%	17.60%	18.78%	10.64%
Return on Capital (ROIC)	16.01%	16.43%	18.86%	19.59%	20.59%	11.69%
Return on Capital Employed (ROCE)	22.80%	23.60%	26.20%	27.30%	28.60%	16.70%
Earnings Yield	6.65%	4.63%	3.46%	2.84%	1.63%	1.19%
FCF Yield	4.03%	4.09%	4.06%	5.38%	1.21%	1.05%
Dividend Yield	0.42%	0.34%	0.28%	0.27%	0.08%	0.10%
Payout Ratio	6.46%	6.93%	6.46%	5.92%	5.00%	8.13%
Buyback Yield / Dilution	2.63%	1.52%	-0.08%	-1.26%	-1.33%	-1.73%
Total Shareholder Return	3.05%	1.86%	0.20%	-0.99%	-1.25%	-1.63%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.